VIMTA LABS
Quarterly Results Analysis [Mar2026]
VIMTA LABS Quarterly Results
| Standalone | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹109 Cr | ₹99 Cr | ₹102 Cr | ₹98 Cr | ₹94 Cr | ₹90 Cr | ₹85 Cr | ₹75 Cr |
| Expenses | ₹70 Cr | ₹64 Cr | ₹68 Cr | ₹64 Cr | ₹61 Cr | ₹57 Cr | ₹55 Cr | ₹49 Cr |
| Operating Income | ₹39 Cr | ₹34 Cr | ₹34 Cr | ₹34 Cr | ₹33 Cr | ₹33 Cr | ₹30 Cr | ₹26 Cr |
| Other Income | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹13 Cr | ₹11 Cr | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹10 Cr | ₹8 Cr | ₹8 Cr |
| Profit Before Tax | ₹29 Cr | ₹23 Cr | ₹26 Cr | ₹25 Cr | ₹25 Cr | ₹24 Cr | ₹22 Cr | ₹18 Cr |
| Profit After Tax | ₹21 Cr | ₹18 Cr | ₹20 Cr | ₹19 Cr | ₹18 Cr | ₹18 Cr | ₹17 Cr | ₹14 Cr |
| EPS | ₹4.73 | ₹3.94 | ₹4.47 | ₹4.25 | ₹4.12 | ₹3.94 | ₹3.84 | ₹3.14 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| VIMTA LABS | 1.6% | -5.6% | -13.7% |
| SAGILITY | -0.5% | -0.9% | -10.4% |
| SYNGENE INTERNATIONAL | -1% | 5.9% | -26.8% |
| PRIME FOCUS | 2.8% | -27.2% | 160.4% |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | 18.9% | 2.9% | -2.5% |
| INDEGENE | -0.5% | 1.9% | -15.2% |
| NESCO | 0.6% | 3.5% | 32.3% |
| LATENT VIEW ANALYTICS | 5.5% | 8.9% | -23.2% |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 29.5% | 46.5% | 8% |
VIMTA LABS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 10.76 % |
| Y-o-Y | 15.68 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹109 Cr | 10.76 | |
| Dec2025 | ₹99 Cr | -3.16 | |
| Sep2025 | ₹102 Cr | 4.39 | |
| Jun2025 | ₹98 Cr | 3.31 | |
| Mar2025 | ₹94 Cr | 5.02 | |
| Dec2024 | ₹90 Cr | 6.11 | |
| Sep2024 | ₹85 Cr | 13.18 | |
| Jun2024 | ₹75 Cr | - | |
VIMTA LABS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 15.00 % |
| Y-o-Y | 19.16 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹39 Cr | 15.00 | |
| Dec2025 | ₹34 Cr | 0.01 | |
| Sep2025 | ₹34 Cr | 1.60 | |
| Jun2025 | ₹34 Cr | 1.98 | |
| Mar2025 | ₹33 Cr | -0.14 | |
| Dec2024 | ₹33 Cr | 10.64 | |
| Sep2024 | ₹30 Cr | 15.32 | |
| Jun2024 | ₹26 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 3.83 % |
| Y-o-Y | 3.03 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 36.04% | 3.83 | |
| Dec2025 | 34.71% | 3.27 | |
| Sep2025 | 33.61% | -2.66 | |
| Jun2025 | 34.53% | -1.29 | |
| Mar2025 | 34.98% | -4.92 | |
| Dec2024 | 36.79% | 4.28 | |
| Sep2024 | 35.28% | 1.88 | |
| Jun2024 | 34.63% | - | |
VIMTA LABS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 20.06 % |
| Y-o-Y | 15.25 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹21 Cr | 20.06 | |
| Dec2025 | ₹18 Cr | -11.72 | |
| Sep2025 | ₹20 Cr | 5.43 | |
| Jun2025 | ₹19 Cr | 3.14 | |
| Mar2025 | ₹18 Cr | 4.58 | |
| Dec2024 | ₹18 Cr | 2.94 | |
| Sep2024 | ₹17 Cr | 22.37 | |
| Jun2024 | ₹14 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 8.41 % |
| Y-o-Y | -0.36 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 19.33 % | 8.41 | |
| Dec2025 | 17.83 % | -8.84 | |
| Sep2025 | 19.56 % | 0.98 | |
| Jun2025 | 19.37 % | -0.15 | |
| Mar2025 | 19.4 % | -0.41 | |
| Dec2024 | 19.48 % | -2.99 | |
| Sep2024 | 20.08 % | 8.13 | |
| Jun2024 | 18.57 % | - | |
VIMTA LABS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 20.05 % |
| Y-o-Y | 14.81 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.73 | 20.05 | |
| Dec2025 | ₹3.94 | -11.86 | |
| Sep2025 | ₹4.47 | 5.18 | |
| Jun2025 | ₹4.25 | 3.16 | |
| Mar2025 | ₹4.12 | 4.57 | |
| Dec2024 | ₹3.94 | 2.60 | |
| Sep2024 | ₹3.84 | 22.29 | |
| Jun2024 | ₹3.14 | - | |
You may also like the below Video Courses
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs NESCO LTD